Astellas and Merck Serono join new alliance for bilharzia in young children
This article was originally published in Scrip
Executive Summary
Major Japanese firms are continuing to build up their activities in the neglected diseases area, with Astellas becoming the latest to take part in a new project to treat schistosomiasis in preschool age children.